Skip to main content
editorial
. 2024 Nov 14;13(6):1034–1037. doi: 10.21037/hbsn-24-568

Figure 2.

Figure 2

Effects of Resmetirom, as reported by the MAESTRO-NAFLD-1 trial. Only selected effects from the study (7) are depicted. Figure created with Biorender.com. BP, blood pressure; FT3, free triiodothyronine; FT4, free thyroxine; HDL, high density lipoprotein; MASLD, metabolic dysfunction-associated steatotic liver disease; RLP, remnant-like particle; SHBG, sex hormone-binding globulin; TSH, thyroid-stimulating hormone; VLDL, very low-density lipoprotein.